See All Slides - tctmd.com

Slides

Presentation TVT 2015

Mitral Valve Implantation

Presenter: Arshad Quadri

June 05, 2015

Presentation

In-Hospital Outcomes and Hospitalization Costs of Peripheral Angioplasty vs Endovascular Stenting

Presenter: SS. Panaich

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: AS With Extreme Comorbidities (the Futile Patient)

Presenter: Howard C. Herrmann, Alec S. Vahanian, David J. Cohen

June 04, 2015

Presentation TVT 2015

Case Presentation: AS With Extreme Comorbidities (the Futile Patient)

Presenter: Howard C. Herrmann, Alec S. Vahanian, Augusto D. Pichard

June 04, 2015

Presentation TVT 2015

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

Presenter: Nicolo Piazza

June 04, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

Thoughtful Commentary: Bioprosthetic Aortic Valve Failure and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Vinayak Bapat

June 04, 2015

Presentation TVT 2015

The Extreme Minimalist Approach: Ad Hoc TAVR

Presenter: Antonio Colombo

June 04, 2015

Presentation TVT 2015

Indirect and Direct Transcatheter Mitral Annuloplasty: Overview and Critical Assessment

Presenter: Ted Feldman, Francesco Maisano, Brian K. Whisenant, Joachim Schofer

June 04, 2015

Presentation TVT 2015

The Contrary Viewpoint: Optimal Outcomes With Selective/Frequent TEE Trumps the Minimalist Strategy

Presenter: Martin B. Leon

June 04, 2015

Advertisement

Slides

Mitral Valve Implantation

In-Hospital Outcomes and Hospitalization Costs of Peripheral Angioplasty vs Endovascular Stenting

Thoughtful Commentary: AS With Extreme Comorbidities (the Futile Patient)

Case Presentation: AS With Extreme Comorbidities (the Futile Patient)

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Thoughtful Commentary: Bioprosthetic Aortic Valve Failure and TAVR

The Extreme Minimalist Approach: Ad Hoc TAVR

Indirect and Direct Transcatheter Mitral Annuloplasty: Overview and Critical Assessment

The Contrary Viewpoint: Optimal Outcomes With Selective/Frequent TEE Trumps the Minimalist Strategy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content